We collect patient-derived and disease-mimicking
conditioned in vitro and in vivo data from physicians and
We curate data based on the professional knowledge of clinicians, chemists, AI specialists, and biologists.
We develop novel drugs based on an AI-powered data science platform.
We efficiently design small molecules by performing in silico simulations based on physicochemical theoretical methods.
We own a verification system based on decades of
novel cancer target discovery focused on cancer stem cell, target verification,
and preclinical/clinical trials with global pharma companies.
Patients Data based first-in-class Drug Screening Platform